The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing-Challenging the "more is better" dogma

Maués, J., Loeser, A., Cowden, J., Johnson, S., Carlson, M., & Lee, S. (2024). The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing—Challenging the “more is better” dogma. Clinical Trials, 21(3), 358–362. https://doi.org/10.1177/17407745241232428
Authors:
Julia Maués
Anne Loeser
Janice Cowden
Sheila Johnson
Martha Carlson
Shing Lee
Affiliated Authors:
Shing Lee
Columbia Affiliation:
Subjects:
Antineoplastic Agents (MeSH)
Patient-Centered Care (MeSH)
Author Keywords:
dose optimization
cancer drug dosing
patient-centered care
personalized medicine
maximum tolerated dose
treatment-related toxicities
real-world effectiveness
post-marketing studies
oncology drug development
patient perspective
elink
Publication Type:
Article
Unique ID:
10.1177/17407745241232428
PMID:
38385314
DOI:
10.1177/17407745241232428
Journal:
Clinical Trials
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: